George Budwell

George Budwell is a biotech and pharmaceutical industry analyst and writer who has contributed extensively to The Motley Fool since 2013. He specializes in coverage of clinical-stage biotechnology companies, drug development pipelines, and healthcare sector investment analysis. Budwell holds expertise in evaluating FDA approval processes and pharmaceutical market dynamics.